283 related articles for article (PubMed ID: 12598253)
1. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans.
Luginbühl M; Gerber A; Schnider TW; Petersen-Felix S; Arendt-Nielsen L; Curatolo M
Anesth Analg; 2003 Mar; 96(3):726-732. PubMed ID: 12598253
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans.
Koppert W; Sittl R; Scheuber K; Alsheimer M; Schmelz M; Schüttler J
Anesthesiology; 2003 Jul; 99(1):152-9. PubMed ID: 12826855
[TBL] [Abstract][Full Text] [Related]
3. Managing chronic whiplash associated pain with a combination of low-dose opioid (remifentanil) and NMDA-antagonist (ketamine).
Lemming D; Sörensen J; Graven-Nielsen T; Lauber R; Arendt-Nielsen L; Gerdle B
Eur J Pain; 2007 Oct; 11(7):719-32. PubMed ID: 17197214
[TBL] [Abstract][Full Text] [Related]
4. Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans.
Tröster A; Sittl R; Singler B; Schmelz M; Schüttler J; Koppert W
Anesthesiology; 2006 Nov; 105(5):1016-23. PubMed ID: 17065897
[TBL] [Abstract][Full Text] [Related]
5. The effects of remifentanil and gabapentin on hyperalgesia in a new extended inflammatory skin pain model in healthy volunteers.
Gustorff B; Hoechtl K; Sycha T; Felouzis E; Lehr S; Kress HG
Anesth Analg; 2004 Feb; 98(2):401-407. PubMed ID: 14742378
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effect of ketamine on remifentanil-induced hyperalgesia: a double-blind, randomized study.
Leal PC; Salomão R; Brunialti MK; Sakata RK
J Clin Anesth; 2015 Jun; 27(4):331-7. PubMed ID: 25910532
[TBL] [Abstract][Full Text] [Related]
7. Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans.
Lenz H; Raeder J; Draegni T; Heyerdahl F; Schmelz M; Stubhaug A
Pain; 2011 Jun; 152(6):1289-1297. PubMed ID: 21396775
[TBL] [Abstract][Full Text] [Related]
8. Plasma cyclic guanosine 3',5'-monophosphate levels: a marker of glutamate-nitric oxide-guanyl cyclase activity?
Engelhardt T; Zaarour C; Crawford MW
J Opioid Manag; 2011; 7(6):462-6. PubMed ID: 22320028
[TBL] [Abstract][Full Text] [Related]
9. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal.
Angst MS; Koppert W; Pahl I; Clark DJ; Schmelz M
Pain; 2003 Nov; 106(1-2):49-57. PubMed ID: 14581110
[TBL] [Abstract][Full Text] [Related]
10. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
Leung A; Wallace MS; Ridgeway B; Yaksh T
Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
[TBL] [Abstract][Full Text] [Related]
11. A comparison of ketamine and paracetamol for preventing remifentanil induced hyperalgesia in patients undergoing total abdominal hysterectomy.
Yalcin N; Uzun ST; Reisli R; Borazan H; Otelcioglu S
Int J Med Sci; 2012; 9(5):327-33. PubMed ID: 22745573
[TBL] [Abstract][Full Text] [Related]
12. Gradual withdrawal of remifentanil infusion may prevent opioid-induced hyperalgesia.
Comelon M; Raeder J; Stubhaug A; Nielsen CS; Draegni T; Lenz H
Br J Anaesth; 2016 Apr; 116(4):524-30. PubMed ID: 26934941
[TBL] [Abstract][Full Text] [Related]
13. Analgesic and cognitive effects of intravenous ketamine-alfentanil combinations versus either drug alone after intradermal capsaicin in normal subjects.
Sethna NF; Liu M; Gracely R; Bennett GJ; Max MB
Anesth Analg; 1998 Jun; 86(6):1250-6. PubMed ID: 9620514
[TBL] [Abstract][Full Text] [Related]
14. Ketamine and remifentanil interactions on the sevoflurane minimum alveolar concentration and acute opioid tolerance in the rat.
Aguado D; Abreu M; Benito J; García-Fernández J; Gómez de Segura IA
Anesth Analg; 2011 Sep; 113(3):505-12. PubMed ID: 21778336
[TBL] [Abstract][Full Text] [Related]
15. The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations?
Kissin I; Bright CA; Bradley EL
Anesth Analg; 2000 Dec; 91(6):1483-8. PubMed ID: 11094005
[TBL] [Abstract][Full Text] [Related]
16. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance.
Laulin JP; Maurette P; Corcuff JB; Rivat C; Chauvin M; Simonnet G
Anesth Analg; 2002 May; 94(5):1263-9, table of contents. PubMed ID: 11973202
[TBL] [Abstract][Full Text] [Related]
17. No evidence for the development of acute tolerance to analgesic, respiratory depressant and sedative opioid effects in humans.
Angst MS; Chu LF; Tingle MS; Shafer SL; Clark JD; Drover DR
Pain; 2009 Mar; 142(1-2):17-26. PubMed ID: 19135798
[TBL] [Abstract][Full Text] [Related]
18. Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man.
Warncke T; Stubhaug A; Jørum E
Pain; 2000 Jun; 86(3):293-303. PubMed ID: 10812259
[TBL] [Abstract][Full Text] [Related]
19. The absence of acute tolerance during remifentanil infusion in volunteers.
Gustorff B; Nahlik G; Hoerauf KH; Kress HG
Anesth Analg; 2002 May; 94(5):1223-8, table of contents. PubMed ID: 11973194
[TBL] [Abstract][Full Text] [Related]
20. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia.
Hood DD; Curry R; Eisenach JC
Anesth Analg; 2003 Sep; 97(3):810-815. PubMed ID: 12933407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
